APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granulocyte-Colony Stimulating Factor (G-CSF)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Analysis and Forecast 2026-2032

21 December 2025214 pages

Choose your research edition.

Industry ResearchGranulocyte-Colony Stimulating Factor (G-CSF) Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Granulocyte-Colony Stimulating Factor (G-CSF) Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Granulocyte-Colony Stimulating Factor (G-CSF) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granulocyte-Colony Stimulating Factor (G-CSF) Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Granulocyte-Colony Stimulating Factor (G-CSF) Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Granulocyte-Colony Stimulating Factor (G-CSF) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Granulocyte-Colony Stimulating Factor (G-CSF) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Granulocyte-Colony Stimulating Factor (G-CSF) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Granulocyte-Colony Stimulating Factor (G-CSF) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Granulocyte-Colony Stimulating Factor (G-CSF) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF) include Changchun GeneScience Pharmaceutical, Evive Biotech, Teva, CSPC Baike Biopharma, Shanghai Sunway Biotech, Sandoz, Amoytop Biotech, Qilu Pharmaceutical and Mylan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Granulocyte-Colony Stimulating Factor (G-CSF), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Granulocyte-Colony Stimulating Factor (G-CSF), also provides the sales of main regions and countries. Of the upcoming market potential for Granulocyte-Colony Stimulating Factor (G-CSF), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Granulocyte-Colony Stimulating Factor (G-CSF) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Granulocyte-Colony Stimulating Factor (G-CSF) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Granulocyte-Colony Stimulating Factor (G-CSF) sales, projected growth trends, production technology, application and end-user industry.

Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Company

Changchun GeneScience Pharmaceutical

Evive Biotech

Teva

CSPC Baike Biopharma

Shanghai Sunway Biotech

Sandoz

Amoytop Biotech

Qilu Pharmaceutical

Mylan

Lunan Pharmaceutical

Kexing Biopharm

Jiangsu Hengrui Pharmaceuticals

Pfizer

North China Pharmaceutical

Hangzhou Jiuyuan Gene Engineering

Harbin Pharmaceutical Group

SL Pharm

Amgen

Tanvex BioPharma

Kashiv BioSciences

Italfarmaco SpA

Coherus BioSciences

Chugai Pharmaceutical

Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Type

Long-acting G-CSF

Short-acting G-CSF

Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Application

Neutropenia

Other

Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granulocyte-Colony Stimulating Factor (G-CSF) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granulocyte-Colony Stimulating Factor (G-CSF) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granulocyte-Colony Stimulating Factor (G-CSF).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Granulocyte-Colony Stimulating Factor (G-CSF) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Granulocyte-Colony Stimulating Factor (G-CSF) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Granulocyte-Colony Stimulating Factor (G-CSF) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Long-acting G-CSF Major Manufacturers Table 3. Short-acting G-CSF Major Manufacturers Table 4. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Neutropenia Major Manufacturers Table 6. Other Major Manufacturers Table 7. Granulocyte-Colony Stimulating Factor (G-CSF) Industry Trends Table 8. Granulocyte-Colony Stimulating Factor (G-CSF) Industry Drivers Table 9. Granulocyte-Colony Stimulating Factor (G-CSF) Industry Opportunities and Challenges Table 10. Granulocyte-Colony Stimulating Factor (G-CSF) Industry Restraints Table 11. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Region (2021-2026) Table 15. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Region (2027-2032) Table 16. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2021-2026) & (k units) Table 18. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2027-2032) & (k units) Table 19. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Region (2021-2026) Table 20. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Region (2027-2032) Table 21. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Manufacturers (2021-2026) Table 25. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Granulocyte-Colony Stimulating Factor (G-CSF) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Granulocyte-Colony Stimulating Factor (G-CSF) Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturers, Product Type & Application Table 29. Global Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Granulocyte-Colony Stimulating Factor (G-CSF) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Type (2021-2026) Table 36. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Type (2027-2032) Table 37. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 39. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2027-2032) & (k units) Table 40. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026) Table 41. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2027-2032) Table 42. Global Granulocyte-Colony Stimulating Factor (G-CSF) Price by Type (2021-2026) & (US$/unit) Table 43. Global Granulocyte-Colony Stimulating Factor (G-CSF) Price by Type (2027-2032) & (US$/unit) Table 44. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Application (2021-2026) Table 48. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Application (2027-2032) Table 49. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 51. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2027-2032) & (k units) Table 52. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2021-2026) Table 53. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2027-2032) Table 54. Global Granulocyte-Colony Stimulating Factor (G-CSF) Price by Application (2021-2026) & (US$/unit) Table 55. Global Granulocyte-Colony Stimulating Factor (G-CSF) Price by Application (2027-2032) & (US$/unit) Table 56. Changchun GeneScience Pharmaceutical Company Information Table 57. Changchun GeneScience Pharmaceutical Business Overview Table 58. Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 60. Changchun GeneScience Pharmaceutical Recent Development Table 61. Evive Biotech Company Information Table 62. Evive Biotech Business Overview Table 63. Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 65. Evive Biotech Recent Development Table 66. Teva Company Information Table 67. Teva Business Overview Table 68. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 70. Teva Recent Development Table 71. CSPC Baike Biopharma Company Information Table 72. CSPC Baike Biopharma Business Overview Table 73. CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 75. CSPC Baike Biopharma Recent Development Table 76. Shanghai Sunway Biotech Company Information Table 77. Shanghai Sunway Biotech Business Overview Table 78. Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 80. Shanghai Sunway Biotech Recent Development Table 81. Sandoz Company Information Table 82. Sandoz Business Overview Table 83. Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 85. Sandoz Recent Development Table 86. Amoytop Biotech Company Information Table 87. Amoytop Biotech Business Overview Table 88. Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 90. Amoytop Biotech Recent Development Table 91. Qilu Pharmaceutical Company Information Table 92. Qilu Pharmaceutical Business Overview Table 93. Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 95. Qilu Pharmaceutical Recent Development Table 96. Mylan Company Information Table 97. Mylan Business Overview Table 98. Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 100. Mylan Recent Development Table 101. Lunan Pharmaceutical Company Information Table 102. Lunan Pharmaceutical Business Overview Table 103. Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 105. Lunan Pharmaceutical Recent Development Table 106. Kexing Biopharm Company Information Table 107. Kexing Biopharm Business Overview Table 108. Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 110. Kexing Biopharm Recent Development Table 111. Jiangsu Hengrui Pharmaceuticals Company Information Table 112. Jiangsu Hengrui Pharmaceuticals Business Overview Table 113. Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 115. Jiangsu Hengrui Pharmaceuticals Recent Development Table 116. Pfizer Company Information Table 117. Pfizer Business Overview Table 118. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 120. Pfizer Recent Development Table 121. North China Pharmaceutical Company Information Table 122. North China Pharmaceutical Business Overview Table 123. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 125. North China Pharmaceutical Recent Development Table 126. Hangzhou Jiuyuan Gene Engineering Company Information Table 127. Hangzhou Jiuyuan Gene Engineering Business Overview Table 128. Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 130. Hangzhou Jiuyuan Gene Engineering Recent Development Table 131. Harbin Pharmaceutical Group Company Information Table 132. Harbin Pharmaceutical Group Business Overview Table 133. Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 135. Harbin Pharmaceutical Group Recent Development Table 136. SL Pharm Company Information Table 137. SL Pharm Business Overview Table 138. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 140. SL Pharm Recent Development Table 141. Amgen Company Information Table 142. Amgen Business Overview Table 143. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 145. Amgen Recent Development Table 146. Tanvex BioPharma Company Information Table 147. Tanvex BioPharma Business Overview Table 148. Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 150. Tanvex BioPharma Recent Development Table 151. Kashiv BioSciences Company Information Table 152. Kashiv BioSciences Business Overview Table 153. Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 155. Kashiv BioSciences Recent Development Table 156. Italfarmaco SpA Company Information Table 157. Italfarmaco SpA Business Overview Table 158. Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 160. Italfarmaco SpA Recent Development Table 161. Coherus BioSciences Company Information Table 162. Coherus BioSciences Business Overview Table 163. Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 165. Coherus BioSciences Recent Development Table 166. Chugai Pharmaceutical Company Information Table 167. Chugai Pharmaceutical Business Overview Table 168. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 170. Chugai Pharmaceutical Recent Development Table 171. North America Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 172. North America Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 173. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 174. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2027-2032) & (k units) Table 175. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Type (2021-2026) & (US$/unit) Table 176. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Type (2027-2032) & (US$/unit) Table 177. North America Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 178. North America Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 179. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 180. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2027-2032) & (k units) Table 181. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Application (2021-2026) & (US$/unit) Table 182. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Application (2027-2032) & (US$/unit) Table 183. North America Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. North America Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. North America Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 187. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (k units) Table 188. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2027-2032) & (k units) Table 189. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Country (2021-2026) & (US$/unit) Table 190. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Country (2027-2032) & (US$/unit) Table 191. United States Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 192. Canada Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 193. Mexico Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 194. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 195. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 196. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 197. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2027-2032) & (k units) Table 198. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Type (2021-2026) & (US$/unit) Table 199. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Type (2027-2032) & (US$/unit) Table 200. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 201. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 202. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 203. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2027-2032) & (k units) Table 204. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Application (2021-2026) & (US$/unit) Table 205. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Application (2027-2032) & (US$/unit) Table 206. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 210. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (k units) Table 211. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2027-2032) & (k units) Table 212. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Country (2021-2026) & (US$/unit) Table 213. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Country (2027-2032) & (US$/unit) Table 214. Germany Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 215. France Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 216. U.K. Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 217. Italy Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 218. Russia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 219. Spain Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 220. Netherlands Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 221. Switzerland Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 222. Sweden Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 223. Poland Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 224. China Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 225. China Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 226. China Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 227. China Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2027-2032) & (k units) Table 228. China Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Type (2021-2026) & (US$/unit) Table 229. China Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Type (2027-2032) & (US$/unit) Table 230. China Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 231. China Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 232. China Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 233. China Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2027-2032) & (k units) Table 234. China Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Application (2021-2026) & (US$/unit) Table 235. China Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Application (2027-2032) & (US$/unit) Table 236. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 237. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 238. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 239. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2027-2032) & (k units) Table 240. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Type (2021-2026) & (US$/unit) Table 241. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Type (2027-2032) & (US$/unit) Table 242. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 243. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 244. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 245. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2027-2032) & (k units) Table 246. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Application (2021-2026) & (US$/unit) Table 247. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Application (2027-2032) & (US$/unit) Table 248. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 249. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 250. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 251. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 252. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (k units) Table 253. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2027-2032) & (k units) Table 254. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Country (2021-2026) & (US$/unit) Table 255. Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Country (2027-2032) & (US$/unit) Table 256. Japan Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 257. South Korea Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 258. India Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 259. Australia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 260. Taiwan Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 261. Southeast Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 262. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 263. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 264. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 265. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2027-2032) & (k units) Table 266. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Type (2021-2026) & (US$/unit) Table 267. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Type (2027-2032) & (US$/unit) Table 268. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 269. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 270. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 271. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2027-2032) & (k units) Table 272. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Application (2021-2026) & (US$/unit) Table 273. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Application (2027-2032) & (US$/unit) Table 274. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 275. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 276. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 277. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 278. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (k units) Table 279. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2027-2032) & (k units) Table 280. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Country (2021-2026) & (US$/unit) Table 281. SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Country (2027-2032) & (US$/unit) Table 282. Brazil Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 283. Argentina Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 284. Chile Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 285. Colombia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 286. Peru Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 287. Saudi Arabia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 288. Israel Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 289. UAE Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 290. Turkey Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 291. Iran Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 292. Egypt Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Table 293. Key Raw Materials Table 294. Raw Materials Key Suppliers Table 295. Granulocyte-Colony Stimulating Factor (G-CSF) Distributors List Table 296. Granulocyte-Colony Stimulating Factor (G-CSF) Customers List Table 297. Research Programs/Design for This Report Table 298. Authors List of This Report Table 299. Secondary Sources Table 300. Primary Sources List of Figures Figure 1. Granulocyte-Colony Stimulating Factor (G-CSF) Image Figure 2. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Long-acting G-CSF Image Figure 5. Short-acting G-CSF Image Figure 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Neutropenia Image Figure 9. Other Image Figure 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2032) & (US$ Million) Figure 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Region (2021-2032) Figure 15. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales (2021-2032) & (k units) Figure 16. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Granulocyte-Colony Stimulating Factor (G-CSF) Sales YoY (2021-2032) & (k units) Figure 19. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales YoY (2021-2032) & (k units) Figure 20. China Granulocyte-Colony Stimulating Factor (G-CSF) Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Granulocyte-Colony Stimulating Factor (G-CSF) Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales YoY (2021-2032) & (k units) Figure 23. Global Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Granulocyte-Col

Scope & coverage.

Types
  • Long-acting G-CSF
  • Short-acting G-CSF
Applications
  • Neutropenia
  • Other
Companies covered
  • Changchun GeneScience Pharmaceutical
  • Evive Biotech
  • Teva
  • CSPC Baike Biopharma
  • Shanghai Sunway Biotech
  • Sandoz
  • Amoytop Biotech
  • Qilu Pharmaceutical
  • Mylan
  • Lunan Pharmaceutical
  • Kexing Biopharm
  • Jiangsu Hengrui Pharmaceuticals
  • Pfizer
  • North China Pharmaceutical
  • Hangzhou Jiuyuan Gene Engineering
  • Harbin Pharmaceutical Group
  • SL Pharm
  • Amgen
  • Tanvex BioPharma
  • Kashiv BioSciences
  • Italfarmaco SpA
  • Coherus BioSciences
  • Chugai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Granulocyte-Colony Stimulating Factor (G-CSF) Market by Type
  3. 1.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Long-acting G-CSF
  5. 1.2.3 Short-acting G-CSF
  6. 1.3 Granulocyte-Colony Stimulating Factor (G-CSF) Market by Application
  7. 1.3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Neutropenia
  9. 1.3.3 Other
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Granulocyte-Colony Stimulating Factor (G-CSF) Market Dynamics
  1. 2.1 Granulocyte-Colony Stimulating Factor (G-CSF) Industry Trends
  2. 2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Industry Drivers
  3. 2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Industry Opportunities and Challenges
  4. 2.4 Granulocyte-Colony Stimulating Factor (G-CSF) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Region
  3. 3.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Region (2021-2026)
  5. 3.2.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Region (2027-2032)
  6. 3.2.4 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region
  9. 3.4.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2021-2026)
  11. 3.4.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2027-2032)
  12. 3.4.4 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Manufacturers
  2. 4.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Manufacturers
  6. 4.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Granulocyte-Colony Stimulating Factor (G-CSF) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Granulocyte-Colony Stimulating Factor (G-CSF) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturers, Product Type & Application
  13. 4.7 Global Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market CR5 and HHI
  16. 4.8.2 2025 Granulocyte-Colony Stimulating Factor (G-CSF) Tier 1, Tier 2, and Tier 3
5 Granulocyte-Colony Stimulating Factor (G-CSF) Market by Type
  1. 5.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type
  2. 5.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type
  6. 5.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Price by Type
6 Granulocyte-Colony Stimulating Factor (G-CSF) Market by Application
  1. 6.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application
  2. 6.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application
  6. 6.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Price by Application
7 Company Profiles
  1. 7.1 Changchun GeneScience Pharmaceutical
  2. 7.1.1 Changchun GeneScience Pharmaceutical Company Information
  3. 7.1.2 Changchun GeneScience Pharmaceutical Business Overview
  4. 7.1.3 Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  6. 7.1.5 Changchun GeneScience Pharmaceutical Recent Developments
  7. 7.2 Evive Biotech
  8. 7.2.1 Evive Biotech Company Information
  9. 7.2.2 Evive Biotech Business Overview
  10. 7.2.3 Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  12. 7.2.5 Evive Biotech Recent Developments
  13. 7.3 Teva
  14. 7.3.1 Teva Company Information
  15. 7.3.2 Teva Business Overview
  16. 7.3.3 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  18. 7.3.5 Teva Recent Developments
  19. 7.4 CSPC Baike Biopharma
  20. 7.4.1 CSPC Baike Biopharma Company Information
  21. 7.4.2 CSPC Baike Biopharma Business Overview
  22. 7.4.3 CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  24. 7.4.5 CSPC Baike Biopharma Recent Developments
  25. 7.5 Shanghai Sunway Biotech
  26. 7.5.1 Shanghai Sunway Biotech Company Information
  27. 7.5.2 Shanghai Sunway Biotech Business Overview
  28. 7.5.3 Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  30. 7.5.5 Shanghai Sunway Biotech Recent Developments
  31. 7.6 Sandoz
  32. 7.6.1 Sandoz Company Information
  33. 7.6.2 Sandoz Business Overview
  34. 7.6.3 Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  36. 7.6.5 Sandoz Recent Developments
  37. 7.7 Amoytop Biotech
  38. 7.7.1 Amoytop Biotech Company Information
  39. 7.7.2 Amoytop Biotech Business Overview
  40. 7.7.3 Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  42. 7.7.5 Amoytop Biotech Recent Developments
  43. 7.8 Qilu Pharmaceutical
  44. 7.8.1 Qilu Pharmaceutical Company Information
  45. 7.8.2 Qilu Pharmaceutical Business Overview
  46. 7.8.3 Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  48. 7.8.5 Qilu Pharmaceutical Recent Developments
  49. 7.9 Mylan
  50. 7.9.1 Mylan Company Information
  51. 7.9.2 Mylan Business Overview
  52. 7.9.3 Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  54. 7.9.5 Mylan Recent Developments
  55. 7.10 Lunan Pharmaceutical
  56. 7.10.1 Lunan Pharmaceutical Company Information
  57. 7.10.2 Lunan Pharmaceutical Business Overview
  58. 7.10.3 Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  60. 7.10.5 Lunan Pharmaceutical Recent Developments
  61. 7.11 Kexing Biopharm
  62. 7.11.1 Kexing Biopharm Company Information
  63. 7.11.2 Kexing Biopharm Business Overview
  64. 7.11.3 Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  66. 7.11.5 Kexing Biopharm Recent Developments
  67. 7.12 Jiangsu Hengrui Pharmaceuticals
  68. 7.12.1 Jiangsu Hengrui Pharmaceuticals Company Information
  69. 7.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  70. 7.12.3 Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  72. 7.12.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  73. 7.13 Pfizer
  74. 7.13.1 Pfizer Company Information
  75. 7.13.2 Pfizer Business Overview
  76. 7.13.3 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  78. 7.13.5 Pfizer Recent Developments
  79. 7.14 North China Pharmaceutical
  80. 7.14.1 North China Pharmaceutical Company Information
  81. 7.14.2 North China Pharmaceutical Business Overview
  82. 7.14.3 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  84. 7.14.5 North China Pharmaceutical Recent Developments
  85. 7.15 Hangzhou Jiuyuan Gene Engineering
  86. 7.15.1 Hangzhou Jiuyuan Gene Engineering Company Information
  87. 7.15.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  88. 7.15.3 Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  90. 7.15.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  91. 7.16 Harbin Pharmaceutical Group
  92. 7.16.1 Harbin Pharmaceutical Group Company Information
  93. 7.16.2 Harbin Pharmaceutical Group Business Overview
  94. 7.16.3 Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  96. 7.16.5 Harbin Pharmaceutical Group Recent Developments
  97. 7.17 SL Pharm
  98. 7.17.1 SL Pharm Company Information
  99. 7.17.2 SL Pharm Business Overview
  100. 7.17.3 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  102. 7.17.5 SL Pharm Recent Developments
  103. 7.18 Amgen
  104. 7.18.1 Amgen Company Information
  105. 7.18.2 Amgen Business Overview
  106. 7.18.3 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  108. 7.18.5 Amgen Recent Developments
  109. 7.19 Tanvex BioPharma
  110. 7.19.1 Tanvex BioPharma Company Information
  111. 7.19.2 Tanvex BioPharma Business Overview
  112. 7.19.3 Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  114. 7.19.5 Tanvex BioPharma Recent Developments
  115. 7.20 Kashiv BioSciences
  116. 7.20.1 Kashiv BioSciences Company Information
  117. 7.20.2 Kashiv BioSciences Business Overview
  118. 7.20.3 Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  120. 7.20.5 Kashiv BioSciences Recent Developments
  121. 7.21 Italfarmaco SpA
  122. 7.21.1 Italfarmaco SpA Company Information
  123. 7.21.2 Italfarmaco SpA Business Overview
  124. 7.21.3 Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  126. 7.21.5 Italfarmaco SpA Recent Developments
  127. 7.22 Coherus BioSciences
  128. 7.22.1 Coherus BioSciences Company Information
  129. 7.22.2 Coherus BioSciences Business Overview
  130. 7.22.3 Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  132. 7.22.5 Coherus BioSciences Recent Developments
  133. 7.23 Chugai Pharmaceutical
  134. 7.23.1 Chugai Pharmaceutical Company Information
  135. 7.23.2 Chugai Pharmaceutical Business Overview
  136. 7.23.3 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  138. 7.23.5 Chugai Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Type
  2. 8.1.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2032)
  3. 8.1.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2032)
  4. 8.1.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Price by Type (2021-2032)
  5. 8.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Application
  6. 8.2.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2032)
  7. 8.2.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2032)
  8. 8.2.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Price by Application (2021-2032)
  9. 8.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country
  10. 8.3.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Type
  2. 9.1.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2032)
  4. 9.1.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Price by Type (2021-2032)
  5. 9.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Application
  6. 9.2.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2032)
  8. 9.2.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Price by Application (2021-2032)
  9. 9.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country
  10. 9.3.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Type
  2. 10.1.1 China Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2032)
  3. 10.1.2 China Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2032)
  4. 10.1.3 China Granulocyte-Colony Stimulating Factor (G-CSF) Price by Type (2021-2032)
  5. 10.2 China Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Application
  6. 10.2.1 China Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2032)
  7. 10.2.2 China Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2032)
  8. 10.2.3 China Granulocyte-Colony Stimulating Factor (G-CSF) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Type
  2. 11.1.1 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2032)
  4. 11.1.3 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Price by Type (2021-2032)
  5. 11.2 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Application
  6. 11.2.1 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2032)
  8. 11.2.3 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Price by Application (2021-2032)
  9. 11.3 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country
  10. 11.3.1 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Granulocyte-Colony Stimulating Factor (G-CSF) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Type
  2. 12.1.1 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Price by Type (2021-2032)
  5. 12.2 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Application
  6. 12.2.1 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Price by Application (2021-2032)
  9. 12.3 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country
  10. 12.3.1 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Granulocyte-Colony Stimulating Factor (G-CSF) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Granulocyte-Colony Stimulating Factor (G-CSF) Value Chain Analysis
  2. 13.1.1 Granulocyte-Colony Stimulating Factor (G-CSF) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Granulocyte-Colony Stimulating Factor (G-CSF) Production Mode & Process
  6. 13.2 Granulocyte-Colony Stimulating Factor (G-CSF) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Distributors
  9. 13.2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst